Cite
Early onset demyelinating Charcot-Marie-Tooth disease caused by a novel in-frame isoleucine deletion in peripheral myelin protein 2.
MLA
Geroldi, Alessandro, et al. “Early Onset Demyelinating Charcot-Marie-Tooth Disease Caused by a Novel in-Frame Isoleucine Deletion in Peripheral Myelin Protein 2.” Journal of the Peripheral Nervous System : JPNS, vol. 25, no. 2, June 2020, pp. 102–06. EBSCOhost, https://doi.org/10.1111/jns.12375.
APA
Geroldi, A., Prada, V., Veneri, F., Trevisan, L., Origone, P., Grandis, M., Schenone, A., Gemelli, C., Lanteri, P., Fossa, P., Mandich, P., & Bellone, E. (2020). Early onset demyelinating Charcot-Marie-Tooth disease caused by a novel in-frame isoleucine deletion in peripheral myelin protein 2. Journal of the Peripheral Nervous System : JPNS, 25(2), 102–106. https://doi.org/10.1111/jns.12375
Chicago
Geroldi, Alessandro, Valeria Prada, Francesca Veneri, Lucia Trevisan, Paola Origone, Marina Grandis, Angelo Schenone, et al. 2020. “Early Onset Demyelinating Charcot-Marie-Tooth Disease Caused by a Novel in-Frame Isoleucine Deletion in Peripheral Myelin Protein 2.” Journal of the Peripheral Nervous System : JPNS 25 (2): 102–6. doi:10.1111/jns.12375.